162 related articles for article (PubMed ID: 22770537)
1. Seven-membered cycloplatinated complexes as a new family of anticancer agents. X-ray characterization and preliminary biological studies.
Cortés R; Crespo M; Davin L; Martín R; Quirante J; Ruiz D; Messeguer R; Calvis C; Baldomà L; Badia J; Font-Bardía M; Calvet T; Cascante M
Eur J Med Chem; 2012 Aug; 54():557-66. PubMed ID: 22770537
[TBL] [Abstract][Full Text] [Related]
2. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
3. Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition.
Albert J; Bosque R; Crespo M; Granell J; López C; Martín R; González A; Jayaraman A; Quirante J; Calvis C; Badía J; Baldomà L; Font-Bardia M; Cascante M; Messeguer R
Dalton Trans; 2015 Aug; 44(30):13602-14. PubMed ID: 26140359
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
[TBL] [Abstract][Full Text] [Related]
5. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
[TBL] [Abstract][Full Text] [Related]
6. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
7. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
[TBL] [Abstract][Full Text] [Related]
8. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
[TBL] [Abstract][Full Text] [Related]
9. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
[TBL] [Abstract][Full Text] [Related]
11. Luminescent pentafluorophenyl-cycloplatinated complexes: synthesis, characterization, photophysics, cytotoxicity and cellular imaging.
Berenguer JR; Pichel JG; Giménez N; Lalinde E; Moreno MT; Piñeiro-Hermida S
Dalton Trans; 2015 Nov; 44(43):18839-55. PubMed ID: 26462143
[TBL] [Abstract][Full Text] [Related]
12. Pt(II) complexes with (N,N') or (C,N,E)(-) (E=N,S) ligands: cytotoxic studies, effect on DNA tertiary structure and structure-activity relationships.
Albert J; Bosque R; Crespo M; Granell J; López C; Cortés R; Gonzalez A; Quirante J; Calvis C; Messeguer R; Baldomà L; Badia J; Cascante M
Bioorg Med Chem; 2013 Jul; 21(14):4210-7. PubMed ID: 23735827
[TBL] [Abstract][Full Text] [Related]
13. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.
Rakić GM; Grgurić-Šipka S; Kaluđerović GN; Bette M; Filipović L; Aranđelović S; Radulović S; Tešić ZLj
Eur J Med Chem; 2012 Sep; 55():214-9. PubMed ID: 22858225
[TBL] [Abstract][Full Text] [Related]
14. Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.
Matesanz AI; Joie C; Souza P
Dalton Trans; 2010 Aug; 39(30):7059-65. PubMed ID: 20571622
[TBL] [Abstract][Full Text] [Related]
15. Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.
Cutillas N; Martínez A; Yellol GS; Rodríguez V; Zamora A; Pedreño M; Donaire A; Janiak C; Ruiz J
Inorg Chem; 2013 Dec; 52(23):13529-35. PubMed ID: 24229419
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.
Guido E; D'Amico G; Russo N; Sicilia E; Rizzato S; Albinati A; Romeo A; Plutino MR; Romeo R
Inorg Chem; 2011 Mar; 50(6):2224-39. PubMed ID: 21341750
[TBL] [Abstract][Full Text] [Related]
17. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
[TBL] [Abstract][Full Text] [Related]
18. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]